Entries by Evolution Biotechnologies

Evolution Biotechnologies selected to participate in InvestEU Matchmaking event 2019

Bedford, UK, February 23rd, 2019 Evolution Biotechnologies (www.evolutionbiotech.com), the UK and US-based company pioneering the use of biological control to benefit human health, today reports that as a holder of the European Seal of Excellence for its work on house dust mite control, it has been selected to participate in the InvestEU Matchmaking event, to […]

Evolution CEO Dr. David Harper interviewed by Proactive Investors

Bedford, UK, January 9th, 2019 Evolution Biotechnologies (www.evolutionbiotech.com), the UK and US-based company pioneering the use of biological control to benefit human health, today reports an interview with CEO Dr. David Harper, conducted by media company Proactive Investors during Biotech Showcase 2019. The interview covered the background to Evolution’s development of a novel, self-replicating control […]

European Patent Office Notifies Intention To Grant for Evolution Biotechnology Patent EP3331366 “Acaricides”

Bedford, UK, January 9th, 2019 Evolution (www.evolutionbiotech.com), the UK and US-based company pioneering the use of biological control to benefit human health, today reports the announcement by the European Patent Office of notification of intention to grant Evolution’s patent EP3331366, “Acaricides”. The patent protects Evolution’s lead technology, developing a biological control for the house dust […]

Evolution Biotechnologies announces presentation at Biotech Showcase, San Francisco, January 7th-9th, 2019

Bedford, UK, October 3rd 2018 Evolution Biotechnologies (www.evolutionbiotech.com), the UK and US-based company pioneering the use of biological control to benefit human health, today announced its intention to present at the Biotech Showcase in San Francisco. CEO Dr. David Harper will present a summary of the company’s activities, along with news of a major development […]

Evolution Biotechnologies announces the appointment of Edward C. Cappabianca as Chief Business Officer

Bedford, UK, December 15th 2018 Evolution Biotechnologies (www.evolutionbiotech.com), the UK and US-based company pioneering the use of biological control in human disease, today announces the appointment of Mr. Edward C. Cappabianca as Chief Business Officer. Mr. Cappabianca has a strong background in investment banking, previously working with Alex. Brown & Sons, William Blair International, and […]

Evolution Biotechnologies announces presentation at LSX World Congress USA, Boston 10-11 October 2018

Bedford, UK, 3 October 2018 ­Evolution Biotechnologies (www.evolutionbiotech.com), the UK and US-based company extending the use of biological control into medically important areas, today announced its intention to present at the LSX World Congress USA, to be held in Boston from 10 to 11 October, 2018. CEO, Dr. David Harper, will present a summary of […]